Documents
Communique of GTTAC meeting of 14 December 2020
Communique of GTTAC meeting of 14 December 2020
This Communiqué covers matters considered at the 23rd video conference of the Gene Technology Technical Advisory Committee (14 December 2020).
Publication type:
Meeting communique
Publication date:
Description:
Licence application DIR 180 from AstraZeneca Pty Ltd is for the import, transport, storage and disposal of a genetically modified (GM) COVID-19 vaccine as part of its commercial supply as a vaccine in Australia.
Last updated: